Compounds > vesnarinone
Page last updated: 2024-08-16

vesnarinone and cyclic gmp

vesnarinone has been researched along with cyclic gmp in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beavo, JA; Harrison, SA; Lathrop, DA; Rapundalo, ST; Schwartz, A1
Ito, M; Konishi, T; Kozeki, H; Masuoka, H; Nakano, T; Sugioka, M; Tanaka, T1
Matsumori, A; Nose, Y; Ono, K; Sasayama, S; Sato, Y; Shioi, T1

Other Studies

3 other study(ies) available for vesnarinone and cyclic gmp

ArticleYear
Cyclic AMP-dependent and cyclic AMP-independent actions of a novel cardiotonic agent, OPC-8212.
    Naunyn-Schmiedeberg's archives of pharmacology, 1988, Volume: 338, Issue:6

    Topics: Action Potentials; Animals; Cardiotonic Agents; Cattle; Cyclic AMP; Cyclic GMP; Electrophysiology; In Vitro Techniques; Membrane Potentials; Phosphodiesterase Inhibitors; Purkinje Fibers; Pyrazines; Quinolines; Sodium; Solvents; Time Factors

1988
Two isoforms of cGMP-inhibited cyclic nucleotide phosphodiesterases in human tissues distinguished by their responses to vesnarinone, a new cardiotonic agent.
    Biochemical and biophysical research communications, 1993, Jan-29, Volume: 190, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aorta; Blood Platelets; Calcium; Calmodulin; Cardiotonic Agents; Cilostazol; Cyclic AMP; Cyclic GMP; Enoximone; Humans; Isoenzymes; Kidney; Myocardium; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazines; Quinolines; Tetrazoles

1993
Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Journal of molecular and cellular cardiology, 1996, Volume: 28, Issue:12

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 8-Bromo Cyclic Adenosine Monophosphate; Amrinone; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Heart Failure; Humans; Interleukin-1; Interleukin-6; Kinetics; Leukocytes, Mononuclear; Lipopolysaccharides; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Pyrazines; Pyridazines; Quinazolines; Quinolines; Tumor Necrosis Factor-alpha

1996